Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Tables)

v3.19.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Schedule of warrants outstanding at various exercise prices
The warrants had various exercise prices and terms as follows as of December 31, 2018:
 
Summary of Warrants
 
Warrants
Outstanding
 
 
Exercise
Price
 
 
Expiration
Date
2015 Financing
(a)
 
 
20,000
 
 
$
6.05
 
 
July 31, 2020
2015 Financing
(b)
 
 
50,000
 
 
 
11.00
 
 
May 11, 2020
2014 Financing
(c)
 
 
1,749,186
 
 
 
5.00
 
 
December 24, 2019
2014 Financing
(c)
 
 
1,500
 
 
 
5.00
 
 
December 18, 2019
2012 Series B private placement
(d)
 
 
—
 
 
 
25.00
 
 
October 24, 2018
Total
 
 
1,820,686
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a)
In connection with the offering on July 31, 2015, the placement agent received warrants to purchase 20,000 shares of common stock at $6.05 per share. The warrants are exercisable and expire on
July 31, 2020
.
 
 
b)
In connection with the offering on May 11, 2015, the placement agent received warrants to purchase 50,000 shares of common stock at $11.00 per share. The warrants are exercisable and expire on
May 11, 2020
.
 
 
c)
In connection with an offering on December 24, 2014, warrants to purchase 3,500,000 shares of common stock at $5.00 per share were purchased and issued for $
0.01
per warrant. The warrants are exercisable and expire on
December 24, 2019
. Also, in connection with the offering on December 24, 2014, the underwriter received warrants to purchase 68,735 shares of common stock at $5.00 per share. The warrants are exercisable and expire on
December 18, 2019
.
 
 
d)
In connection with a private placement offering on October 25, 2012, warrants to purchase 400,001 shares of common stock at $25.00 per share were issued. The warrants expired on
October 24, 2018
.